Skip to main content

Technical guidelines for risk assessment of heavy metals in traditional Chinese medicines

Abstract

Background

Heavy metals are considered a global concern because they can deteriorate human health. This guideline aims to scientifically evaluate health risk of heavy metals in TCM and to propose a reference for decision making in developing TCM-related health policies.

Methods

Using a multidisciplinary approach, a steering committee oversaw the development of the guideline. To obtain a reasonable and accurate risk assessment, key exposure assessment parameters for TCM, e.g., exposure frequency (EF), exposure duration (ED), and daily ingestion rate (IR) were obtained from surveys. In addition, transfer rates for heavy metals from Chinese medicinal materials (CMM) to decoctions or preparations were examined.

Results

Based on the scientific theory of risk control, the guideline was designed systematically, and principles and procedures for the risk assessment of heavy metals in TCM were identified. The guideline can be utilized to assess the risk of heavy metals in CMM and Chinese patent medicines (CPM).

Conclusion

This guideline may help standardize the risk assessment of heavy metals in TCM, advance regulatory standards for heavy metals in TCM, and ultimately improve human health through scientific TCM usage in clinic.

Background

With the ever-increasing popularity of Traditional Chinese medicine (TCM) and the global expansion of the TCM market, safety has become a major concern for both public health institutions and the general population [1]. TCM products include Chinese medicinal materials (CMM) and Chinese patent medicines (CPM). CMM are natural products found in the environment, with potential contamination by heavy metals during the processes of cultivation, harvesting, and processing. CPM are preparations composed of different types of CMM, thus heavy metals in CMM are likely to be transferred to CPM, resulting in their contamination. Heavy metal contamination represents a serious threat, as they are ubiquitous in the environment, non-biodegradable, persistent and toxic, even at extremely low levels [2,3,4,5,6,7,8,9,10,11,12,13]. The heavy metal problem has become a major factor affecting the quality and safety of TCM, attracting the attention of both society and regulatory agencies [14,15,16,17].

International organizations such as the Food and Agriculture Organization of the United Nations/World Health Organization (FAO/WHO), European Food Safety Authority (ESFA), Agency for Toxic Substances and Disease Registry (ATSDR), United States Environmental Protection Agency (US EPA), and Agency for Toxic Substances and Diseases Registry (ATSDR) have assessed the safety of food-related chemicals for a long time [18,19,20]. Risk assessment represents the central scientific part of risk analysis, and primarily addresses the need for optimal decisions for preventing disease and improving public health. Risk assessment of chemicals can be generally described as characterizing the potential hazards and the associated risks to life and health after human exposure for a given time period. However, TCM are different from food: they are used for the treatment of diseases and are less frequently consumed compared with food. Therefore, to develop a risk assessment model suitable to TCM, conventional models should be refined and a guideline readily applicable to the characteristics of TCM developed by regulatory authority is urgently needed.

Methods

Guideline design and development were performed in accordance with the “World Health Organization Handbook for Guideline Development” , under the direction of Dr. Shuangcheng Ma, the Chairman of WHO Collaborating Center for Herbal Medicine. The research was approved by National Medical Products Administration (NMPA).

Before drafting

Several aspects were considered before drafting the guideline. Firstly, risk assessment of heavy metals in TCM should be based on the fact that TCM are natural products. During the modernization of TCM, centralized and large-scale artificial cultivation is inevitable. Thus, it is impossible to achieve zero pollution or no residue. The main goals of risk assessment are to scientifically assess the health risk of heavy metals in TCM, to ensure the safe usage of TCM, and to guide the healthy development of the TCM industry. Secondly, TCM differs from food in terms of intake (exposure). Thus, it is suggested to establish exposure parameters that could reflect the characteristics of TCM, including exposure frequency (EF), exposure duration (Ed), daily ingestion rate (IR), in order to accurately evaluate the risk conferred by heavy metals in TCM. Thirdly, during risk assessment, one should consider the risk–benefit balance to determine acceptable risk levels for the different clinical purposes of TCM.

Constitution of a steering committee and a multidisciplinary panel

The steering committee is the Professional Committee of Chinese Pharmacopoeia Commission for Safety and Quality Control of traditional Chinese medicine (TCM), consisting of 11 specialists and TCM experts in TCM, agriculture and food safety risk assessment. The roles of this committee were to design the research, to provide guidance and to perform a review of study contents and methodologies. The multidisciplinary panel comprised experts from drug control institutes, scientific researchers and public health policy makers, with the goal of establishing a representative and reliable survey and database of heavy metal contents in TCM. The panel was responsible for conducting the study.

Systematic review and evaluation

Studies on health risk assessment of heavy metals were systematically reviewed. The principles and procedures established by various organizations, including FAO/WHO, ESFA, US EPA, and ATSDR, were reviewed and adopted as a foundation for the development of our risk assessment guideline. In addition, many databases, including CDSR, CMR, HTA, NHSEED, EMBASE, Ovid MEDLINE(R), China Journals Full-text Database and CNKI, were searched for relevant publications either in Chinese or English.

Survey and questionnaires

For ensuring an accurate assessment of health risks related to TCM intake, a questionnaire-based TCM use survey was carried out in 11 Chinese provinces/cities, including Beijing, Liaoning, Heilongjiang, Jiangsu, Zhejiang, Shandong, Hubei, Guangdong, Chongqing, Yunnan, and Gansu. Totally 20,917 randomly selected volunteers (9420 males and 11,497 females) were enrolled. In terms of age, 72.63%, 19.51% and 7.86% of these individuals were 18–44, 45–59 and > 60 years old, respectively. Participant age averaged 37.8 years. The participants included 11,358 urban and 9559 rural residents. Both face-to-face and hospital prescription surveys were utilized for the identification of significant factors affecting heavy metal exposure.

The face-to-face survey was carried out by the multi-stage stratified cluster random-sampling method. The basic demographic information of the volunteers, ingestion purpose, ingestion mode, EF, ED, and IR were assessed. The hospital prescription survey was performed in four Beijing hospitals to assess TCM prescriptions. Totally 300 to 800 prescriptions were collected from each hospital. Patient gender, patient age, dosage form, TCM ingredients in each prescription, and administration mode were examined. After the survey, the data were collected by Epidata’s double entry to generate a database for further analysis and building risk assessment models for heavy metals in TCM.

Consumption of TCM by residents from different provinces

In this survey, 21.84% of respondents used TCM in the past 6 months, with higher reported usage in women (24.21%) compared with that in men (18.96%). There was a statistically significant difference (P < 0.01) in the rate of TCM usage among survey respondents from different provinces, with the highest reported rates in Guangdong Province (45.20%) and Jiangsu Province (31.18%), followed by Gansu Province (22.03%), Zhejiang Province (21.24%), and Shandong Province (20.75%). In contrast, the rate of TCM usage was between 10 and 20% in Heilongjiang Province, Liaoning Province, Yunnan Province, and Hubei Province, while Chongqing City (11.61%) and Beijing City (11.45%) had the lowest TCM consumption rates.

Consumption of TCM by different population categories

Consumption of TCM by residents of different ages, academic qualifications, occupations, educational levels, and incomes was shown in Table 1. From the survey, it could be concluded that there were several key factors affecting the consumption rate of TCM, involving gender, age, province of residence, and occupation. The results showed that women, older adults, retirees, and respondents from Guangdong Province were more likely to consume TCM. Additionally, the most common TCM consumption mode was decoction (49.10%). Less common modes of TCM consumption included soaking TCM in wine (2.49%) or taking TCM with food (1.91%).

Table 1 TCM used in different population categories

Exposure frequency and daily ingestion rate

The results of the survey, including questionnaire on TCM exposure frequency and daily ingestion rate, were shown in Table 2 and Table 3. In addition, a total of 2193 TCM prescriptions were collected from 4 hospitals in Beijing. Data including sex, age, total amount of TCM prescribed, administration method were obtained (Table 4). Collectively, based on the results from survey and hospital prescriptions, P95 values for EF and ED were 90 days per year and 20 years, respectively. Average and P95 value for IR were 200 g and 500 g, respectively.

Table 2 TCM exposure frequency (days/year)
Table 3 TCM daily ingestion ratev (g)
Table 4 Statistics on the consumption of TCM prescribed by the hospitals

Establishing a database of heavy metals in TCM

From 2016 to 2019, heavy metal contents in commonly used TCM were monitored to establish a database to support risk assessment. Totally 9,300 batches for 140 TCM samples were obtained from wild or cultivated areas, TCM markets, and retail pharmacies. The samples were collected for three years, with each variety having no less than 20 batches per year, to generate a database with wide coverage and strong representativeness. The collection sites encompassed diverse environmental areas in China (82°31′ E to 131°15′ E and 19°07′ N to 48°52′ N). Sample authentication was performed by Dr. Shuai Kang, a scientist experienced in CMM identification. After review by the experts of the steering committee, 14 drug control institutes and scientific research institutes were selected to establish a representative and reliable database of heavy metal contents in TCM, serving for risk assessment. The TCM specimens underwent digestion in a microwave, and heavy metals in TCM were analyzed by ICP-MS [21]. For ensuring the quality of the analysis, blanks, duplicates, spikes, and internal standard recoveries were examined throughout the whole process.

Drafting the guideline

Two TCM practitioners and one risk assessment expert were tasked to develop a framework for the guideline.

Contents of the guideline

Purpose

The primary purpose of the current guideline is to (i) lay out principles and methods for the risk assessment of heavy metals in TCM, (ii) facilitate the application of scientific approaches in the risk assessment of heavy metals in TCM, (iii) identify high-risk heavy metal indicators based on risk assessment in the final analysis, offering suggestions for risk management.

Scope

The guideline provides principles and general procedures for evaluating the risk conferred by heavy metals found in TCM, including lead (Pb), cadmium (Cd), arsenic (As), mercury (Hg) and copper (Cu), etc. The guideline is adequate for both CMM and CPM. In this principle, the risk assessment of TCM as homologous varieties of medicine and food is carried out according to their medicinal effects.

Glossary

The glossaries in this guideline include Risk assessment, Deterministic estimate, Lowest-observed-adverse-effect level (LOAEL), No-observed-adverse-effect level (NOAEL), Benchmark dose (BMD), Benchmark dose lower confidence limit (BMDL), Provisional maximum tolerable daily intake (PMTDI), Provisional tolerable monthly intake (PTMI), Provisional tolerable weekly intake (PTWI), Health based guidance value (HBGV), and Lifetime cancer risk (CR), which are listed in Additional file 1: Appendix S1 [22,23,24,25,26,27,28,29,30].

The four steps of risk assessment for heavy metals in TCM

Risk assessment is a strategy focusing on the understanding and evaluation of chemicals’ hazards and exposures, ultimately evaluating the associated health risks. It encompasses four steps, including hazard identification, hazard characterization, exposure assessment and risk characterization.

Hazard Identification Hazard Identification aims to identify the types and natures of adverse effects caused by heavy metals in TCM. This step mainly addresses the following two questions: 1) the natures of health hazards that heavy metals in TCM might pose in humans; 2) the conditions in which an identified hazard could be expressed. Using a variety of data, such as animal studies, epidemiological data, and/or structure–activity relationship, the nature of toxicity and involved organs or tissues are determined.

Hazard Characterization This second step is a qualitative and, wherever possible, quantitative assessment of the inherent features of heavy metals in TCM potentially causing adverse effects. This includes, if possible, the assessment of a dose–response relationship or the establishment of HBGV (for example, PTWI and PTMI for heavy metals) to provide a quantitative expression of the range of exposure level expected to without appreciable health risk.

Exposure Assessment This represents the third step of risk assessment, evaluating the likely intake of heavy metals via TCM for a target population, based on heavy metals’ contents in TCM and clinical consumption data for TCM [31, 32].

For heavy metals in CMM, the equation for deriving the daily exposure level was established as follows:

$$\mathrm{Exp}=\frac{\mathrm{EF}\times \mathrm{ED}\times \mathrm{IR}\times \mathrm{C}\times \mathrm{t}}{\mathrm{AT}\times \mathrm{W}}$$
(1)

where Exp is the daily exposure level (μg/kg/bw) of CMM; EF represents exposure frequency (day/year) determined from the survey (the provisional P95 value of EF is 90 days/year); ED represents exposure duration (20 years for TCM); IR is the daily ingestion rate of CMM (g/day), and its provisional mean and P95 values are 200 g and 500 g, respectively, based on the survey; C is heavy metals’ concentration in CMM (mg/kg); t is transfer rate for heavy metals from CMM to decoctions or preparations (%); AT represents the average time of exposure to CMM (365 days/year × 70 years); W represents the body weight (kg) with a mean of 63 kg for adults, and may need to be adjusted for certain patient groups, nationalities,etc.

For heavy metals in CPM, the equation for determining the daily exposure level was established as follows:

$$\mathrm{Exp}=\frac{\mathrm{EF}\times \mathrm{Ed}\times \mathrm{IR}\times \mathrm{C}}{\mathrm{AT}\times \mathrm{W}}$$
(2)

where Exp is the daily exposure level (μg/kg/bw) of CPM; EF represents exposure frequency (day/year) determined from the survey (provisional P95 value of 90 days/year); Ed is exposure duration (years), i.e., 20 years for TCM; IR is daily ingestion rate for CPM (g/day) based on the instructions of the CPM; C is heavy metals’ concentration in CPM (mg/kg); AT is the average time of exposure to CPM (365 days/year × 70 years); W represents the body weight (kg) with a mean of 63 kg in adults, and may need to be adjusted for certain patient groups, nationalities,etc.

Risk Characterization This final step of risk assessment integrates Hazard Identification, Hazard Characterization and Exposure Assessment to estimate likely adverse effects in a given population. Risk Characterization estimates the probability of occurrence of known and potential adverse effects exerted by heavy metals. The derived information might be qualitative or quantitative. Different strategies have been applied for the risk characterization of toxic effects viewed as non-carcinogenic or carcinogenic. The Hazard Quotient (HQ) approach is commonly used for non-carcinogenic risk characterization, while the lifetime cancer risk (CR) approach is usually applied for carcinogenic risk characterization.

For non-carcinogenic risk characterization, the HQ approach is commonly used. Here, estimated or measured human exposures are usually compared with the HBGV of heavy metals. The equation for determining HQ was established as follows:

$${\text{HQ}} = \frac{{{\text{Exp}} \times 10}}{{\text{ HBGV}}}$$
(3)

where Exp is the daily exposure level calculated by Eq. 1 (for CMM) or Eq. 2 (for CPM); 10 is the safety factor, indicating a daily intake of heavy metals from TCM below 10% of their total daily intake; HBGV is usually provided by international regulatory organizations (Additional file 3: Table S1). The HQ approach assumes that in cases with HQ ≤ 1 the level of exposure is unlikely to cause an adverse health effect. In this case, the risk is considered to be acceptable and generally no further risk mitigation measures are needed. On the other hand, if HQ exceeds 1, adverse effects induced by the exposure cannot be excluded, and recommendations are generally put forward for more comprehensive assessments; alternatively, actions are proposed to reduce possible exposures to heavy metals.

For carcinogenic risk characterization, the CR approach is commonly used, which is calculated by the cancer slope factor (CSF) of a given heavy metal carcinogen, e.g., Pb or As. The equation for determining CR has been established as follows [33, 34]:

$$\mathrm{CR}=\mathrm{Exp}\times \mathrm{CSF}$$
(4)

where Exp is the daily exposure level calculated by Eq. 1 (for CMM) or Eq. 2 (for CPM); CSF represents the oral cancer slope factor, with values for As and Pb of 1.5 and 8.5 × 10–3 (mg/kg/day)−1, respectively. The CR approach assumes that in case of CR above 10–4, the carcinogenic risk of the specific carcinogenic heavy metal over a lifetime is considered to be unacceptable.

Complement

In risk assessment, the description of uncertainties should consider the toxicological characteristics of heavy metals in TCM, exposure data, assessment models and hypothetical situations. In addition, technical measures to reduce the uncertainties should also be proposed if necessary. The risk assessment described in the guideline considers TCM serving as therapeutic medicines. When used as dietary supplement or food, assessment parameters for TCM may be altered. In addition, when the medicine is used as a short-term emergency medicine or a long-term chronic medicine, the use frequency and dosage should be adjusted. The risk–benefit balance should be determined based on the clinical purpose.

Health-based guidance levels have been determined by various authoritative organizations, including Joint FAO/WHO Expert Committee on Food Additives (JECFA), USEPA, ATSDR and EFSA. HBGV details are listed in Additional file 3: Table S1.

Discussion

The results of our database were basically consistent with those reported in the literatures [35, 36]. Based on the database of heavy metals in 9,300 batches of TCM the following conclusion could be obtained: (1) The average levels of Cd, As, Hg, Pb and Cu were 0.29, 0.41, 0.07, 1.35 and 7.47 mg/kg, respectively. (2) The general over-limit ratios of Pb, Cd, As, Hg, and Cu were low; however, contamination in certain TCM cannot be ignored, involving the Pb contents in Morinda officinalis How and the Cd contents in Curcuma phaeocaulis VaL., Lonicera macranthoides Hand. -Mazz., and Lindera aggregata (Sims) Kos-term. Thus, continuous risk monitoring and assessment are recommended. (3) In view of different segments of the herbal plants used in the clinic, leaves and herbs exhibited the highest over-limit ratios, followed by roots and rhizomes. And the over-limit ratios of fruits and seeds were the lowest for all four metals. (4) There were differences in the degree of heavy metal contamination in TCM from different origins. (5) The differences in heavy metal contents between cultivated and wild TCM should not be ignored. (6) Probably due to the fact that animal medicines were at a higher position of the food chain and their main components (including proteins, peptides, and amino acids) chelating with heavy metals, the contents of heavy metals were generally higher than those in herbal medicines.

The risk assessment approaches listed in the guideline are classic deterministic estimates for heavy metals in TCM considering exposure to one heavy metal. In the process of deterministic risk assessment, inputs are represented by single-point estimates. The details of deterministic risk assessment results for heavy metals in TCM using the database established in this study are provided in Additional file 2: Appendix S2. Probabilistic risk assessment considers the effects of uncertainty and variability, and then estimates the range and likelihood of exposure risks, avoiding overestimation or underestimation of health risks and facilitating decision-making [37]. The distribution of parameters instead of a fixed parameter’s value is applied in the probabilistic risk model, enabling a stochastic behavior and probability distribution for the output to be investigated, which should be examined in the future [38]. Additionally, human beings are exposed to multiple pollutants in many ways in real life [39]. Exposure to numerous contaminants through diverse media and pathways is defined as cumulative exposure. Accordingly, cumulative risk assessment is the assessment of health risks produced by cumulative exposure. Cumulative risk assessment strategies for heavy metal contaminants in TCM should be explored in the future to address co-exposure to multiple heavy metals.

Scientific risk assessment is the basis for developing reasonable standard limits. Utilizing the risk assessment approaches in the current guideline, “Guidelines for Establishment of Limit for Harmful Residue of Traditional Chinese Medicine” in the Chinese Pharmacopoeia 2020 edition was established. Compared with the guideline listed in the Chinese Pharmacopoeia 2015 edition, the 2020 edition guideline was especially revised to improve the equation for calculating theoretical limits for exogenous harmful residues, including heavy metals [40]. An advanced equation suitable for TCM was proposed to calculate realistic theoretical limits for heavy metals. Moreover, utilizing the risk assessment approaches in the present guideline and comprehensively considering factors such as public health, economic development, and human cognition, solid safety limit guidance values for all TCM were provided and listed in the 2020 edition of Chinese Pharmacopoeia for the first time.

Conclusion

In conclusion, this is the first survey-based technical guideline for assessing health risks conferred by heavy metals in TCM in China. The guideline has the ability to scientifically assess the health risks of heavy metals in TCM through a comprehensive application of TCM’s EF, ED and IR from surveys. In addition, safety factors and transfer rates for heavy metals were highlighted. This technical guideline will benefit public health with a standardized risk assessment tool for heavy metals in TCM, advance regulatory standards for heavy metals in TCM and improve human health through scientific TCM usage in the clinic.

Availability of data and materials

Details of data mining, selection, extraction and assessment carried out to support the findings of this study are available from the corresponding author upon request.

Abbreviations

TCM:

Traditional Chinese medicine

CMM:

Chinese medicinal materials

CPM:

Chinese patent medicine

WHO:

World health organization

HBGV:

Health based guidance value

JECFA:

Joint FAO/WHO Expert Committee on Food Additives

BMD:

Benchmark dose

BMDL:

Benchmark dose lower confidence limit

LOAEL:

Lowest-observed-adverse-effect level

NOAEL:

No-observed-adverse-effect level

PMTDI:

Provisional maximum tolerable daily intake

PTMI:

Provisional tolerable monthly intake

PTWI:

Provisional tolerable weekly intake

HQ:

Hazard quotient

CR:

Lifetime cancer risk

CSF:

Cancer slope factor

References

  1. WHO. WHO Traditional Medicine Strategy 2014–2023. Geneva: World health organization; 2013.

    Google Scholar 

  2. Bassil M, Daou F, Hassan H, et al. Lead, cadmium and arsenic in human milk and their socio-demographic and lifestyle determinants in Lebanon. Chemosphere. 2018;191:911–21.

    Article  CAS  PubMed  Google Scholar 

  3. Barakat MA. New trends in removing heavy metals from industrial wastewater. Arab J Chem. 2011;4:361–77.

    Article  CAS  Google Scholar 

  4. Chen X, Wang K, Wang Z, et al. Effects of lead and cadmium co-exposure on bone mineral density in a Chinese population. Bone. 2014;63(6):76–80.

    Article  CAS  PubMed  Google Scholar 

  5. Kippler M, Tofail F, Hamadani JD, Grantham-McGregor M, Bottai MV, et al. Early-life cadmium exposure and child development in 5-yearOld girls and boys: a cohort study in rural Bangladesh. Environ Health Perspect. 2012;120:1462–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Sanders AP, Claus Henn B, Wright RO. Perinatal and childhood exposure to cadmium, manganese, and metal mixtures and effects on cognition and behavior: a review of recent literature. Curr Environ Heal Reports. 2015;2:284–94.

    Article  CAS  Google Scholar 

  7. Zhang WL, Du Y, Zhai MM, et al. Cadmium exposure and its health effects: a 19-year follow-up study of a polluted area in China. Sci Total Environ. 2014;470:224–8.

    Article  PubMed  Google Scholar 

  8. Fallahzadeh RA, Ghaneian MT, Miri M, et al. Spatial analysis and health risk assessment of heavy metals concentration in drinking water resources. Environ Sci Pollut Res. 2017;24:24790–802.

    Article  CAS  Google Scholar 

  9. Kapaj S, Peterson H, Liber K, et al. Human health effects from chronic arsenic poisoning-a review. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2006;41:2399–428.

    Article  CAS  PubMed  Google Scholar 

  10. Zukowska J, Biziuk M. Methodological evaluation of method for dietary heavy metal intake. J Food Sci. 2010;73:21–9.

    Article  Google Scholar 

  11. Lee SL, Li X, Shi W, et al. Metal contamination in urban, suburban, and country park soils of Hong Kong: a study based on GIS and multivariate statistics. Sci Total Environ. 2006;356:45–61.

    Article  CAS  PubMed  Google Scholar 

  12. Schober SE, Sinks TH, Jones RL, et al. Blood mercury levels in US children and women of childbearing age, 1999–2000. JAMA. 2003;289:1667–74.

    Article  CAS  PubMed  Google Scholar 

  13. Zang XD, Huang HSY, Zhuang ZL, et al. The association between serum copper concentrations and cardiovascular disease risk factors in children and adolescents in NHANES. Environ Sci Pollut Res Int. 2018;25:16951–8.

    Article  CAS  PubMed  Google Scholar 

  14. ATSDR (Agency for Toxic Substances and Disease Registry). Child Health Initiative. Healthy Children; Toxic Environments. Acting on the Unique Vulnerability of Children Who Dwell Near Hazardous Waste Sites. Atlanta, GA: ATSDR. 1997.

  15. Bangs GW. Revisions to the Exposure Assessment Guidelines of 1992: Proposed Changes and Panel Discussion. The International Society of Exposure Analysis (ISEA) 15th Annual Conference, October 30-November 3, Tucson, AZ.2005.

  16. Sobhanardakani S. Potential health risk assessment of Cr, Cu, Fe and Zn for human population via consumption of commercial spices; A case study of hamedan City. Iran Int Arch Health Sci. 2016;3(3):119–24.

    Article  CAS  Google Scholar 

  17. Brauer M, Hakkinen BPJ, Gehan BM, et al. Communicating exposure and health effects results to study subjects, the community and the public: strategies and challenges. J Expo Anal Environ Epidemiol. 2004;14:479–83.

    Article  PubMed  Google Scholar 

  18. CDC. Second National Report on Biochemical Indicators of Diet and Nutrition in the U.S. Population. Executive Summary. Atlanta, GA: CDC. 2012.

  19. NRC. Models in Environmental Regulatory Decision Making. Washington, D.C: The National Academies Press; 2007.

    Google Scholar 

  20. NRC. Exposure Science in the 21st Century: A Vision and a Strategy. Washington, D.C: The National Academies Press; 2012.

    Google Scholar 

  21. Zuo TT, Jin HY, Zhang L, et al. Innovative health risk assessment of heavy metals in Chinese herbal medicines based on extensive data. Pharmacol Res. 2020;159:1104987.

    Article  Google Scholar 

  22. FAO/WHO. Codex Alimentarius Commission procedural manual, 18th ed. Rome, Food and Agriculture Organization of the United Nations, Codex Alimentarius Commission. 2008.

  23. IPCS. Principles of toxicokinetic studies. Geneva, World Health Organization, International Programme on Chemical Safety (Environmental Health Criteria, No. 57). 1986.

  24. IPCS. Principles for the safety assessment of food additives and contaminants in food. Geneva, World Health Organization, International Programme on Chemical Safety (Environmental Health Criteria, No. 70). 1987.

  25. IPCS. Principles for the toxicological assessment of pesticide residues in food. Geneva, World Health Organization, International Programme on Chemical Safety (Environmental Health Criteria, No. 104). 1990.

  26. IPCS.Assessing human health risks of chemicals: derivation of guidance values for health-based exposure limits. Geneva, World Health Organization, International Programme on Chemical Safety (Environmental Health Criteria, No. 170). 1994.

  27. IPCS.IPCS risk assessment terminology. Geneva, World Health Organization, International Programme on Chemical Safety (Harmonization Project Document, No. 1). 2004.

  28. IPCS. Uncertainty and data quality in exposure assessment. Geneva, World Health Organization, International Programme on Chemical Safety (Harmonization Project Document, No. 6).2008.

  29. IPCS.Principles for modelling dose-response for the risk assessment of chemicals. Geneva, World Health Organization, International Programme on Chemical Safety (Environmental Health Criteria, No. 239). 2009.

  30. WHO. Food consumption and exposure assessment of chemicals. Report of an FAO/WHO Consultation on Food Consumption and Exposure Assessment of Chemicals, Geneva, World Health Organization.1997.

  31. Roba C, Roşu C, Piştea I, et al. Heavy metal content in vegetables and fruits cultivated in Baia Mare mining area (Romania) and health risk assessment. Environ Sci Pollut Res. 2016;23:6062–73.

    Article  CAS  Google Scholar 

  32. Singh A, Sharma RK, Agrawal M, et al. Health risk assessment of heavy metals via dietary intake of foodstuffs from the wastewater irrigated site of a dry tropical area of India. Food Chem Toxicol. 2010;48:611–9.

    Article  CAS  PubMed  Google Scholar 

  33. OECD (Organization for Economic Cooperation and Development). Guidelines for testing of chemicals. Carcinogenicity studies. No. 451. Paris, France. 1981.

  34. Epa US. Review of revised sections of the proposed guidelines for carcinogen risk assessment. Washington, DC: Science Advisory Board; 1999.

    Google Scholar 

  35. Xue CCL, Zhang AL, Lin V, Da Costa C, Story DF. Complementary and alternative medicine use in Australia: a national population-based survey. J Altern Complement Med. 2007;13(6):643–50.

    Article  PubMed  Google Scholar 

  36. Han XL, Zhang XB, Guo LP, et al. Statistical analysis of heavy metal pollution in traditional Chinese Medicine Chin. J Chin Mater Med. 2008;33(18):2041.

    Google Scholar 

  37. Fallahzadeh RA, Khosravi R, Dehdashti B, et al. Spatial distribution variation and probabilistic risk assessment of exposure to chromium in ground water supplies; a case study in the east of Iran. Food Chem Toxicol. 2018;115:260–6.

    Article  CAS  PubMed  Google Scholar 

  38. Gholizadeh A, Mokhtari M, Naimi N, et al. Assessment of corrosion and scaling potential in groundwater resources; a case study of Yazd-Ardakan Plain. Iran Groundwater for Sustainable Development. 2017;5:59–65.

    Article  Google Scholar 

  39. Tsatsakis AM, Docea AO, Tsitsimpikou C. New challenges in risk assessment of chemicals when simulating real exposure scenarios; simultaneous multi-chemicals’ low dose exposure. Food Chem Toxicol. 2016;96:174–6.

    Article  CAS  PubMed  Google Scholar 

  40. The Pharmacopoeia Commission of the People's Republic of China (2020 Edition). Beijing, China: Pharmacopoeia of the People’s Republic of China, Chinese Medical Science and Technology Publishers.2020.

Download references

Acknowledgements

The authors would like to thank all the researchers and experts for this study.

Funding

This work was financially supported by the 13th 5 Year National Significant New Drugs Creation Feature Subjects (2018ZX09735006) and Youth Development Research Foundation of NIFDC (2020A3).

Author information

Authors and Affiliations

Authors

Contributions

TTZ drafted the manuscript and conducted the assessment. LZ conducted the survey. YW, LXN MRS, LNL searched the literature. JDY and FW gave suggestions and revised the manuscript. SCM and HYJ designed the study. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Hong-Yu Jin, Feng Wei or Shuang-Cheng Ma.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

All the authors were concerned and agreed to publish before the submission.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1:

Glossary.

Additional file 2:

Deterministic risk assessment results for heavy metals in TCM.

Additional file 3: Table S1.

HBGV of heavy metals from different sources.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zuo, TT., Zhang, L., Wang, Y. et al. Technical guidelines for risk assessment of heavy metals in traditional Chinese medicines. Chin Med 18, 69 (2023). https://doi.org/10.1186/s13020-023-00771-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13020-023-00771-3

Keywords